|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 546.29 USD | -3.33% |
|
+3.15% | -2.73% |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| 06-05 | PriorNilsson Evolve Global rose 3.64 percent in May - trimmed positions in Beijer Alma and OEM | FW |
| Market Cap | 16.14B 14.12B 13.02B 12.06B 22.9B 1,532B 23.27B 156B 60.69B 756B 60.59B 59.28B 2,613B | P/E 2026 * |
33.3x | P/E 2027 * | 30.5x |
|---|---|---|---|---|---|
| Enterprise Value | 14.97B 13.1B 12.07B 11.19B 21.24B 1,421B 21.58B 145B 56.3B 701B 56.2B 54.98B 2,424B | EV / Sales 2026 * |
5.4x | EV / Sales 2027 * | 4.93x |
| Free-Float |
80.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | -3.33% | ||
| 1 week | +3.15% | ||
| Current month | +3.15% | ||
| 1 month | +19.30% | ||
| 3 months | +7.43% | ||
| 6 months | -10.90% | ||
| Current year | -2.73% |
| 1 week | 530.98 |  | 567.91 |
| 1 month | 445 | | 567.91 |
| Current year | 373 | | 628.92 |
| 1 year | 306.7 | | 628.92 |
| 3 years | 227.21 | | 628.92 |
| 5 years | 126.94 | | 628.92 |
| 10 years | 21.76 | | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 65 | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Director | 72 | 0.0003% | ||
| 06-29 | Fiscal year | Director | 56 | 0.0002% | ||
| 06-29 | Fiscal year | Director | 66 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.33% | +3.15% | +71.30% | +131.94% | 16.14B | |
| -1.03% | +5.24% | +2.94% | +9.41% | 50.25B | |
| +0.25% | +1.70% | +419.39% | +621.71% | 40.39B | |
| +1.10% | +7.77% | +28.18% | -3.96% | 34.38B | |
| -0.16% | +8.42% | +28.20% | +63.00% | 34.4B | |
| +1.31% | -0.56% | +5.12% | +33.90% | 26.32B | |
| -0.35% | +0.09% | - | - | 16.64B | |
| +0.32% | +0.53% | +14.33% | +21.47% | 13.71B | |
| +3.79% | +8.88% | +106.63% | +106.63% | 13.75B | |
| -1.63% | +9.78% | +1,764.71% | +697.48% | 12.69B | |
| Average | +0.07% | +8.75% | +271.20% | +186.84% | 25.87B | |
| Weighted average by Cap. | +0.08% | +6.58% | +183.30% | +170.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77B 2.43B 2.24B 2.07B 3.94B 263B 4B 26.83B 10.43B 130B 10.42B 10.19B 449B | 2.95B 2.58B 2.38B 2.2B 4.18B 280B 4.25B 28.5B 11.08B 138B 11.06B 10.82B 477B |
| Net income | 493M 431M 397M 368M 699M 46.76B 710M 4.76B 1.85B 23.08B 1.85B 1.81B 79.76B | 540M 473M 436M 404M 766M 51.25B 779M 5.22B 2.03B 25.29B 2.03B 1.98B 87.43B |
| Net Debt | -1.17B -1.02B -943M -874M -1.66B -111B -1.69B -11.3B -4.4B -54.75B -4.39B -4.29B -189B | -1.62B -1.42B -1.3B -1.21B -2.3B -154B -2.33B -15.65B -6.08B -75.78B -6.07B -5.94B -262B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$546.29 | -3.33% | 356,311 |
| 26-07-06 | US$565.09 | +1.34% | 234,162 |
| 26-07-02 | US$557.60 | +2.58% | 356,575 |
| 26-07-01 | US$543.57 | +2.64% | 312,635 |
| 26-06-30 | US$529.59 | -0.96% | 335,554 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
